X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (988) 988
Publication (81) 81
Book Review (5) 5
Book Chapter (2) 2
Newsletter (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (802) 802
female (610) 610
male (593) 593
index medicus (478) 478
hematology (472) 472
adult (467) 467
middle aged (445) 445
vidarabine - analogs & derivatives (435) 435
transplantation (429) 429
busulfan - administration & dosage (395) 395
busulfan (361) 361
oncology (358) 358
transplantation conditioning - methods (340) 340
aged (285) 285
immunology (271) 271
bone-marrow-transplantation (266) 266
busulfan - therapeutic use (266) 266
adolescent (265) 265
busulfan - analogs & derivatives (259) 259
vidarabine - administration & dosage (250) 250
transplantation, homologous (236) 236
stem cells (225) 225
hematopoietic stem cells (215) 215
treatment outcome (212) 212
stem-cell transplantation (209) 209
hematopoietic stem cell transplantation (192) 192
child (186) 186
fludarabine (186) 186
versus-host-disease (174) 174
animals (168) 168
hematopoietic stem cell transplantation - methods (168) 168
antineoplastic combined chemotherapy protocols - therapeutic use (161) 161
chemotherapy (161) 161
retrospective studies (161) 161
vidarabine - therapeutic use (154) 154
young adult (151) 151
cyclophosphamide (149) 149
disease-free survival (146) 146
child, preschool (145) 145
graft vs host disease - prevention & control (145) 145
busulfan - adverse effects (144) 144
transplantation conditioning (144) 144
hematology, oncology and palliative medicine (129) 129
leukemia (128) 128
survival analysis (128) 128
cancer (122) 122
hematopoietic stem cell transplantation - adverse effects (122) 122
acute myeloid-leukemia (118) 118
therapy (115) 115
busulfan - pharmacology (110) 110
cyclophosphamide - administration & dosage (110) 110
total-body irradiation (107) 107
mortality (106) 106
risk factors (105) 105
recurrence (103) 103
survival rate (103) 103
care and treatment (100) 100
stem cell transplantation (99) 99
transplantation conditioning - adverse effects (99) 99
graft vs host disease - etiology (97) 97
treosulfan (97) 97
health aspects (94) 94
infant (93) 93
research (91) 91
hematologic neoplasms - therapy (89) 89
hematologic malignancies (88) 88
mice (88) 88
follow-up studies (87) 87
leukemia, myeloid, acute - therapy (86) 86
myeloablative agonists - therapeutic use (85) 85
pharmacokinetics (85) 85
children (84) 84
immunosuppressive agents - therapeutic use (81) 81
pharmacology & pharmacy (80) 80
analysis (79) 79
dosage and administration (78) 78
bone marrow transplantation (75) 75
toxicity (75) 75
bone marrow (73) 73
graft survival (73) 73
article (72) 72
daily intravenous busulfan (72) 72
graft vs host disease - mortality (72) 72
remission induction (72) 72
time factors (72) 72
combined modality therapy (71) 71
conditioning regimen (70) 70
cyclophosphamide - therapeutic use (70) 70
whole-body irradiation (69) 69
prospective studies (67) 67
antineoplastic agents (66) 66
dose-response relationship, drug (66) 66
myeloablative agonists - administration & dosage (66) 66
preparative regimen (66) 66
unrelated donors (66) 66
busulfan - pharmacokinetics (65) 65
antilymphocyte serum - administration & dosage (63) 63
immunosuppressive agents - administration & dosage (61) 61
vidarabine - adverse effects (60) 60
antineoplastic agents, alkylating - therapeutic use (58) 58
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (941) 941
Japanese (15) 15
Chinese (13) 13
German (10) 10
French (5) 5
Spanish (3) 3
Italian (2) 2
Russian (2) 2
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 11, pp. 1687 - 1695
Journal Article
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, ISSN 1083-8791, 11/2014, Volume 20, Issue 11, pp. 1687 - 1695
Clofarabine (Clo), fludarabine (Flu), and busulfan (Bu) are used in pre-transplant conditioning therapy for patients with myeloid leukemia. To further improve... 
AML | busulfan | fludarabine | clofarabine | FLT3 | Sorafenib
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 07/2014, Volume 55, Issue 7, pp. 1625 - 1634
Journal Article
Experimental Hematology, ISSN 0301-472X, 2012, Volume 40, Issue 10, pp. 800 - 810
Hematopoietic stem cell transplantation is used for treatment of lymphoma. In an attempt to design an efficacious and safe prehematopoietic stem cell... 
Hematology, Oncology and Palliative Medicine | Advanced Basic Science | CLOFARABINE | MEDICINE, RESEARCH & EXPERIMENTAL | RIBONUCLEOTIDE REDUCTASE | REPAIR | INHIBITION | DAILY INTRAVENOUS BUSULFAN | DOUBLE-STRAND BREAKS | ATM | HEMATOLOGY | FLUDARABINE | MOLECULAR-MECHANISMS | TRANSPLANTATION | Melphalan - agonists | Busulfan - agonists | Humans | Antineoplastic Agents, Alkylating - pharmacology | Deoxycytidine - pharmacology | Antineoplastic Agents, Alkylating - agonists | Deoxycytidine - agonists | Transplantation, Homologous | DNA (Cytosine-5-)-Methyltransferases - metabolism | DNA-Binding Proteins - metabolism | Dose-Response Relationship, Drug | Lymphoma - metabolism | Lymphoma - therapy | Lymphoma - pathology | Epigenesis, Genetic - drug effects | Melphalan - pharmacology | Transplantation Conditioning - methods | Hydroxamic Acids - pharmacology | Protein-Serine-Threonine Kinases - metabolism | Busulfan - pharmacology | Tumor Suppressor Proteins - metabolism | Drug Screening Assays, Antitumor - methods | Cell Cycle Proteins - metabolism | Hematopoietic Stem Cell Transplantation | Azacitidine - analogs & derivatives | Ataxia Telangiectasia Mutated Proteins | Azacitidine - agonists | Drug Synergism | Azacitidine - pharmacology | Cytotoxins | Hydroxamic Acids - agonists | Cell Line, Tumor | Checkpoint Kinase 2 | Cell Proliferation - drug effects | Deoxycytidine - analogs & derivatives | Antimitotic agents | Methyltransferases | Analysis | Nucleosides | Lymphomas | Transplantation | Antineoplastic agents | Methylation | Hematopoietic stem cells | SAHA | drug cytotoxicity Category | Hematological Malignancies or Stem Cell Transplantation | nucleoside analog | lymphoma | DNA alkylator
Journal Article
Leukemia, ISSN 0887-6924, 02/2015, Volume 29, Issue 2, pp. 396 - 405
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 5/2012, Volume 53, Issue 5
Hematopoietic stem cell transplantation (HSCT) is a promising treatment for lymphomas. Its success depends on effective pre-transplant conditioning regimens.... 
busulfan | DNA alkylating agent | SAHA | gemcitabine | clofarabine | lymphoma
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 04/2018, Volume 141, Issue 4, pp. 1417 - 1426.e1
Allogeneic hematopoietic stem cell transplantation (HSCT) is used as a therapeutic approach for primary immunodeficiencies (PIDs). The best outcomes have been... 
hematopoietic stem cell transplantation | CD3+ T-cell receptor αβ+ cell depletion | haploidentical | mismatched unrelated | Primary immunodeficiency | cell depletion | CD3 | T-cell receptor αβ | Busulfan - analogs & derivatives | Immunologic Deficiency Syndromes - therapy | Humans | Antilymphocyte Serum - immunology | Child, Preschool | Hematopoietic Stem Cell Transplantation | Infant | Male | Receptors, Antigen, T-Cell, alpha-beta - immunology | Thiotepa - immunology | Vidarabine - analogs & derivatives | Graft vs Host Disease - immunology | CD3 Complex - immunology | Vidarabine - immunology | Female | Graft vs Host Disease - prevention & control | Retrospective Studies | Transplantation Conditioning - methods | Busulfan - immunology | Immunologic Deficiency Syndromes - immunology | Child | Alemtuzumab - immunology | Antigens, CD19 - immunology | Graft-versus-host reaction | Transplants & implants | Liver | Prophylaxis | Stem cell transplantation | Transplantation | Lymphocytes T | Infections | Treosulfan | Drug resistance | Grafting | Hematopoietic stem cells | T-cell receptor | Demographics | Lymphocytes | Children | Busulfan | Conditioning | Cytomegalovirus | Immunoglobulins | CD19 antigen | Neutrophils | Health risks | Immunodeficiency | Transplants | CD3 antigen | T cell receptors | Patients | Survival | Hemopoiesis | Graft rejection | Rejection | Fludarabine | Grafts | Depletion | Globulins | Thymocytes | Adenoviruses | Stem cells | Monoclonal antibodies | Histocompatibility antigen HLA | Methods | Viral infections
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2018, Volume 24, Issue 3, pp. 529 - 536
Journal Article